BioCatalyst

OCU400 Low Dose, OCU400 Med Dose, OCU400 High Dose, OCU400 Second Eye Dosing — catalyst calendar

1 verified catalyst event(s) referencing OCU400 Low Dose, OCU400 Med Dose, OCU400 High Dose, OCU400 Second Eye Dosing, each linked to its official source. Verified as of 2026-10-31.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and L
Phase 1/2 · Retinitis Pigmentosa, Leber Congenital Amaurosis
 OCGN Ocugen, Inc. OCU400 Low Dose, OCU400 Med Dose, OCU400 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.